Publications.

Matthijs Versteegh 4/19/23 Matthijs Versteegh 4/19/23

The value of health in a cost-effectiveness analysis: theory vs practice

Read More

Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine

Matthijs Versteegh 4/16/21 Matthijs Versteegh 4/16/21

Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine

Read More

Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision

Matthijs Versteegh 2/19/21 Matthijs Versteegh 2/19/21

Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision

Read More

Severity-Adjusted Probability of Being Cost Effective

Matthijs Versteegh 5/27/19 Matthijs Versteegh 5/27/19

Severity-Adjusted Probability of Being Cost Effective

Read More

Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool

Matthijs Versteegh 8/28/18 Matthijs Versteegh 8/28/18

Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool

Read More

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

Matthijs Versteegh 6/9/16 Matthijs Versteegh 6/9/16

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

Read More